Non-proprietary Name Injection
NDC Package 85551-123-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Non-proprietary Name (l- arginine) injection is l-Arginine HCl Injection is contraindicated in:Patients with known hypersensitivity to L-Arginine, benzyl alcohol, or any component of the formulation. This formulation utilizes a injection delivery system. Marketed by Xseer Pharmaceuticals, this product is identified by NDC 85551-123.

Identification & Billing

NDC Package Code
85551-123-30
Package Description
30 mL in 1 VIAL, GLASS
Product Code
85551-123
11-Digit Billing Format
85551012330

Clinical Specifications

Proprietary Name
Non-proprietary Name
Non-Proprietary Name
L- Arginine
Substance Name
Arginine Hydrochloride
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
ARGININE HYDROCHLORIDE 100 mg/mL
Usage Information
L-Arginine HCl Injection is contraindicated in:Patients with known hypersensitivity to L-Arginine, benzyl alcohol, or any component of the formulation. Neonates, premature infants, or low birth weight infants due to the risk of benzyl alcohol toxicity (“gasping syndrome”). Patients with severe metabolic acidosis or conditions where administration of hypertonic solutions may worsen fluid or electrolyte imbalance. Patients with severe renal impairment or anuria unless clinically justified and closely monitored by a healthcare professional. Patients with hyperchloremic acidosis or known disorders of amino acid metabolism where L-Arginine administration may be inappropriate.

Regulatory & Marketing

Labeler Name
Xseer Pharmaceuticals
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
06-01-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85551-123-30 identifies a specific commercial package of 30 ml in 1 vial, glass of Non-proprietary Name, a human prescription drug labeled by Xseer Pharmaceuticals. This injection is formulated for intramuscular; intravenous use and contains arginine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Xseer Pharmaceuticals on June 01, 2026. The current certification is valid through December 31, 2027.

How is this Xseer Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85551012330. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85551-123-30
11-Digit CMS (5-4-2)
85551-0123-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.